Index RUT
P/E 57.31
EPS (ttm) 2.14
Insider Own 0.58%
Shs Outstand 42.81M
Perf Week 6.48%
Market Cap 5.24B
Forward P/E 9.34
EPS next Y 13.11
Insider Trans 3.39%
Shs Float 42.56M
Perf Month 2.91%
Income 100.80M
PEG 2.08
EPS next Q 2.82
Inst Own 116.25%
Short Float 15.93%
Perf Quarter -13.05%
Sales 3.90B
P/S 1.34
EPS this Y 65.58%
Inst Trans 1.21%
Short Ratio 9.85
Perf Half Y -22.22%
Book/sh 65.39
P/B 1.87
EPS next Y 29.98%
ROA 1.39%
Short Interest 6.78M
Perf Year -27.46%
Cash/sh 5.85
P/C 20.91
EPS next 5Y 27.50%
ROE 4.78%
52W Range 101.60 - 176.85
Perf YTD -10.20%
Dividend Est. -
P/FCF -
EPS past 5Y -23.54%
ROI 1.54%
52W High -30.77%
Beta 1.71
Dividend TTM -
Quick Ratio 0.98
Sales past 5Y 30.23%
Gross Margin 27.48%
52W Low 20.50%
ATR (14) 5.61
Dividend Ex-Date -
Current Ratio 1.27
EPS Y/Y TTM 650.46%
Oper. Margin 12.72%
RSI (14) 53.00
Volatility 3.90% 4.41%
Employees 11637
Debt/Eq 1.48
Sales Y/Y TTM 69.77%
Profit Margin 2.58%
Recom 1.43
Target Price 184.95
Option/Short Yes / Yes
LT Debt/Eq 1.37
EPS Q/Q 2212.87%
Payout 0.00%
Rel Volume 1.65
Prev Close 124.31
Sales Surprise -6.40%
EPS Surprise -11.94%
Sales Q/Q 14.56%
Earnings Aug 02 BMO
Avg Volume 688.61K
Price 122.43
SMA20 4.24%
SMA50 -6.53%
SMA200 -11.65%
Trades
Volume 1,134,675
Change -1.51%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-16-24 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$175
May-08-24 Resumed
Barclays
Equal Weight
$193
May-06-24 Reiterated
TD Cowen
Buy
$260 → $265
Apr-18-24 Resumed
Morgan Stanley
Equal-Weight
$200
Mar-19-24 Upgrade
UBS
Neutral → Buy
$152 → $170
Feb-29-24 Reiterated
TD Cowen
Outperform
$230 → $260
Jan-04-24 Upgrade
Raymond James
Outperform → Strong Buy
$190
Sep-25-23 Initiated
HSBC Securities
Buy
$212
Aug-09-23 Upgrade
Wells Fargo
Equal Weight → Overweight
$162 → $224
Jul-14-23 Initiated
CapitalOne
Equal Weight
$174
Jul-12-23 Downgrade
Raymond James
Strong Buy → Outperform
Jun-02-23 Resumed
JP Morgan
Neutral
$138
May-08-23 Initiated
CL King
Buy
$165
Mar-21-23 Initiated
Evercore ISI
Outperform
$217
Jan-04-23 Upgrade
Raymond James
Mkt Perform → Strong Buy
$160
Nov-22-22 Downgrade
Goldman
Buy → Neutral
$259 → $150
Nov-18-22 Downgrade
Piper Sandler
Overweight → Neutral
$228 → $133
Nov-14-22 Downgrade
Wells Fargo
Overweight → Equal Weight
$248 → $148
Oct-19-22 Initiated
Jefferies
Buy
$250
Sep-15-22 Upgrade
Goldman
Neutral → Buy
$200 → $259
Show Previous Ratings
Sep-19-24 11:05PM
Sep-13-24 03:00PM
Sep-11-24 04:13PM
Sep-04-24 09:00AM
Aug-29-24 07:30AM
04:28AM
Loading…
Aug-27-24 04:28AM
Aug-23-24 08:34AM
Aug-16-24 08:11AM
Aug-14-24 05:00PM
Aug-13-24 07:30AM
Aug-05-24 04:51PM
(Morningstar Research) -8.01%
+5.36%
Aug-03-24 06:08AM
(Thomson Reuters StreetEvents)
Aug-02-24 02:55PM
(Morningstar Research) -18.10%
09:30AM
07:40AM
06:40AM
Loading…
06:40AM
(Associated Press Finance)
06:30AM
Aug-01-24 07:37PM
Jul-30-24 09:15AM
Jul-28-24 12:44PM
Jul-26-24 10:00AM
Jul-22-24 06:30AM
Jul-16-24 07:46PM
Jul-11-24 06:30AM
Jul-05-24 06:30AM
Jul-02-24 01:54PM
Jun-28-24 12:00PM
Jun-26-24 06:30AM
Jun-13-24 06:30AM
Jun-10-24 06:30AM
04:40PM
Loading…
Jun-03-24 04:40PM
May-31-24 07:00AM
May-30-24 07:02AM
May-28-24 10:52PM
06:30AM
May-14-24 04:16PM
May-10-24 06:30AM
May-06-24 10:11AM
09:09AM
May-04-24 08:31AM
May-03-24 11:28PM
(Thomson Reuters StreetEvents) +6.90%
04:49PM
10:53AM
09:30AM
08:52AM
07:50AM
06:55AM
06:47AM
(Associated Press Finance)
06:30AM
May-02-24 08:34AM
May-01-24 12:45PM
Apr-26-24 10:00AM
Apr-16-24 03:56PM
11:22AM
Apr-15-24 12:45PM
10:33AM
09:55AM
06:30AM
Apr-10-24 06:30AM
Apr-09-24 04:05PM
Apr-08-24 04:30PM
Apr-04-24 06:30PM
Mar-28-24 06:30AM
Mar-27-24 04:53PM
Mar-25-24 04:45AM
Mar-21-24 11:36AM
Mar-20-24 04:15PM
Mar-19-24 11:14AM
Mar-18-24 04:15PM
Mar-11-24 08:55AM
Mar-07-24 01:22PM
11:58AM
06:05AM
Mar-06-24 06:30AM
Mar-01-24 07:31AM
Feb-29-24 11:23AM
09:30AM
Feb-28-24 11:23PM
(Thomson Reuters StreetEvents) +12.31%
01:19PM
12:02PM
09:30AM
08:32AM
07:00AM
(Associated Press Finance)
06:30AM
Feb-23-24 09:15AM
Feb-12-24 02:46PM
03:14AM
Feb-09-24 04:54PM
Feb-07-24 04:58AM
Feb-01-24 05:36AM
Jan-30-24 04:36AM
Jan-26-24 05:14PM
(Morningstar Research) -7.54%
+8.13%
04:15PM
Jan-10-24 07:30AM
Dec-28-23 08:30AM
Dec-22-23 07:30AM
Dec-16-23 07:02AM
Dec-07-23 04:15PM
Dec-05-23 09:48PM
(Morningstar Research) -5.14%
Dec-04-23 05:30AM
Chart Industries, Inc. engages in the manufacturing of engineered equipment for the industrial gas, energy, and biomedical industries. It operates through the following business segments: Cryo Tank Solutions, Heat Transfer Systems, Specialty Products and Repair, Service & Leasing, and Corporate. The Cryo Tank Solutions segment supplies bulk, microbulk, and mobile equipment used in the storage, distribution, vaporization, and application of industrial gases. The Heat Transfer Systems segment supplies mission engineered equipment and systems used in the separation, liquefaction, and purification of hydrocarbon and industrial gases. The Specialty Products segment supplies products used in specialty market applications including hydrogen, HLNG vehicle tanks, food and beverage, space exploration, lasers, cannabis, and water treatment. The Repair, Service, and leasing segment includes repair and service centers globally, which provides installation, service, repair, maintenance, and refurbishment of cryogenic products, as well as global equipment leasing solutions. The Corporate segment includes operating expenses for executive management, accounting, tax, treasury, corporate development, human resources, information technology, investor relations, legal, internal audit, and risk management. The company was founded in 1992 and is headquartered in Ball Ground, GA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Harty Linda S Director Sep 16 '24 Buy 48.05 5,000 240,230 5,000 Sep 16 05:09 PM Hotchkiss Herbert VP, GC and Secretary Sep 16 '24 Buy 117.72 212 24,957 212 Sep 16 04:49 PM Harty Linda S Director Sep 13 '24 Buy 113.50 1,000 113,500 10,640 Sep 13 11:17 AM Mahoney Paul E Director Sep 11 '24 Buy 106.55 500 53,275 2,107 Sep 11 11:47 AM Evanko Jillian C. President and CEO Sep 05 '24 Buy 114.31 440 50,296 125,448 Sep 05 10:11 AM Harty Linda S Director May 16 '24 Buy 155.00 500 77,500 9,355 May 16 04:21 PM Evanko Jillian C. President and CEO May 10 '24 Buy 153.44 490 75,186 125,008 May 10 04:02 PM Harty Linda S Director Dec 15 '23 Buy 130.14 1,000 130,140 8,310 Dec 15 03:47 PM Harty Linda S Director Dec 14 '23 Buy 134.44 500 67,222 7,310 Dec 14 10:42 AM CICHOCKI ANDREW R Director Dec 11 '23 Buy 126.88 400 50,753 1,177 Dec 11 03:02 PM
Index RUT
P/E 18.67
EPS (ttm) 1.64
Insider Own 0.79%
Shs Outstand 191.10M
Perf Week 6.78%
Market Cap 5.82B
Forward P/E 13.17
EPS next Y 2.32
Insider Trans -1.77%
Shs Float 189.00M
Perf Month -2.37%
Income 320.40M
PEG 0.89
EPS next Q 0.50
Inst Own 94.57%
Short Float 3.38%
Perf Quarter -4.59%
Sales 3.70B
P/S 1.57
EPS this Y 5.21%
Inst Trans -0.81%
Short Ratio 3.76
Perf Half Y -11.12%
Book/sh 9.16
P/B 3.33
EPS next Y 23.17%
ROA 9.68%
Short Interest 6.38M
Perf Year -16.31%
Cash/sh 2.06
P/C 14.79
EPS next 5Y 20.90%
ROE 18.44%
52W Range 25.46 - 39.95
Perf YTD 4.55%
Dividend Est. 0.37 (1.22%)
P/FCF 13.76
EPS past 5Y 5.66%
ROI 13.24%
52W High -23.55%
Beta 2.38
Dividend TTM 0.36 (1.18%)
Quick Ratio 1.25
Sales past 5Y 29.04%
Gross Margin 31.27%
52W Low 19.95%
ATR (14) 0.80
Dividend Ex-Date Oct 04, 2024
Current Ratio 1.99
EPS Y/Y TTM 31.90%
Oper. Margin 13.35%
RSI (14) 52.60
Volatility 2.56% 2.37%
Employees 7100
Debt/Eq 0.40
Sales Y/Y TTM -4.73%
Profit Margin 8.66%
Recom 1.33
Target Price 39.75
Option/Short Yes / Yes
LT Debt/Eq 0.39
EPS Q/Q -43.00%
Payout 21.63%
Rel Volume 1.65
Prev Close 30.77
Sales Surprise -6.45%
EPS Surprise -22.27%
Sales Q/Q -3.60%
Earnings Jul 24 AMC
Avg Volume 1.70M
Price 30.54
SMA20 1.82%
SMA50 -3.44%
SMA200 -3.78%
Trades
Volume 2,798,736
Change -0.75%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-08-24 Downgrade
Piper Sandler
Overweight → Neutral
$38 → $32
Oct-17-23 Upgrade
Barclays
Equal Weight → Overweight
$33 → $42
Jul-14-23 Initiated
CapitalOne
Overweight
$40
Oct-06-22 Downgrade
Barclays
Overweight → Equal Weight
$38 → $28
Aug-25-22 Initiated
The Benchmark Company
Buy
$32
Jul-15-22 Upgrade
BofA Securities
Neutral → Buy
$25 → $22
Apr-11-22 Upgrade
Piper Sandler
Neutral → Overweight
$28 → $30
Mar-11-22 Downgrade
BofA Securities
Buy → Neutral
Feb-22-22 Upgrade
Goldman
Sell → Neutral
$24
Sep-17-21 Initiated
Goldman
Sell
$22
Feb-25-21 Reiterated
Cowen
Outperform
$22 → $26
Dec-22-20 Initiated
Goldman
Buy
$21
Oct-30-20 Reiterated
Cowen
Outperform
$13 → $18
Sep-16-20 Initiated
Scotiabank
Sector Outperform
$12
Sep-11-20 Initiated
Credit Suisse
Outperform
$13
Sep-08-20 Upgrade
Evercore ISI
In-line → Outperform
$16
Jun-26-20 Initiated
Stifel
Buy
$15
Jun-22-20 Initiated
BofA/Merrill
Buy
$12
Show Previous Ratings
Aug-16-24 07:00AM
Aug-15-24 10:34AM
Jul-25-24 02:14PM
Jul-24-24 05:00PM
Jul-10-24 11:58AM
04:00PM
Loading…
Jul-09-24 04:00PM
Jul-05-24 11:00AM
Jul-03-24 03:00PM
Jul-02-24 05:00PM
Jun-17-24 01:30PM
May-31-24 06:21PM
May-16-24 07:00AM
May-07-24 03:55PM
Apr-25-24 01:23PM
Apr-24-24 09:53PM
05:00PM
Loading…
05:00PM
Apr-22-24 09:39AM
Apr-19-24 03:21PM
Apr-09-24 04:30PM
Apr-05-24 08:00AM
Apr-03-24 08:36AM
05:32AM
Apr-02-24 12:09PM
11:53AM
09:51AM
(The Wall Street Journal)
07:37AM
Mar-26-24 10:44AM
Mar-22-24 05:00AM
Feb-28-24 07:52AM
Feb-27-24 07:00AM
10:29AM
Loading…
Feb-13-24 10:29AM
Feb-07-24 05:11PM
12:30PM
08:45AM
Feb-05-24 05:36PM
04:30PM
Jan-31-24 09:15AM
Jan-29-24 10:00AM
Jan-26-24 06:59PM
Jan-16-24 06:47PM
Jan-03-24 04:30PM
Nov-10-23 07:00AM
Oct-26-23 02:27PM
01:28PM
Oct-24-23 06:13PM
04:30PM
Oct-03-23 07:00AM
Sep-28-23 07:00AM
Aug-30-23 04:30PM
Jul-25-23 09:27PM
Jul-24-23 04:30PM
Jun-29-23 06:35PM
(Morningstar Research) +5.51%
07:00AM
Jun-21-23 08:00PM
08:00PM
Jun-06-23 07:00AM
May-25-23 04:09PM
(Investor's Business Daily)
May-11-23 04:30PM
Apr-26-23 08:00PM
08:00PM
12:30PM
06:01AM
Apr-24-23 04:30PM
Apr-04-23 07:00AM
Mar-15-23 06:52PM
(Morningstar Research) -6.74%
Mar-02-23 10:40AM
(Investor's Business Daily)
Mar-01-23 07:00AM
Feb-16-23 04:30PM
Feb-15-23 04:30PM
Feb-04-23 07:16AM
Feb-03-23 12:58AM
Feb-01-23 04:30PM
Jan-11-23 07:00AM
Jan-06-23 06:48PM
Dec-21-22 01:45PM
(Investor's Business Daily)
Nov-30-22 08:00AM
Nov-10-22 04:30PM
Nov-08-22 01:46PM
(Investor's Business Daily)
Oct-25-22 04:30PM
Oct-19-22 07:00AM
Oct-05-22 06:00AM
Sep-30-22 02:12PM
(Investor's Business Daily)
07:00AM
Sep-29-22 07:00AM
Aug-11-22 04:30PM
Jul-27-22 07:14AM
Jul-26-22 04:30PM
Jun-29-22 07:00AM
Jun-27-22 06:32AM
Jun-07-22 08:45AM
May-12-22 04:30PM
May-11-22 08:32AM
Apr-26-22 04:30PM
Apr-22-22 09:00AM
Apr-19-22 03:01PM
Apr-11-22 07:00AM
Apr-04-22 07:00AM
Mar-30-22 12:35PM
Mar-07-22 04:30PM
Feb-09-22 04:30PM
ChampionX Corp. engages in the provision of chemistry solutions, artificial lift systems, and engineered equipment and technologies. It operates through the following segments: Production Chemical Technologies, Production and Automation Technologies, Drilling Technologies, and Reservoir Chemical Technologies. The Production Chemical Technologies segment offers products and services that cover a broad range of onshore and offshore chemical solutions in production and midstream operations. The Production and Automation Technologies focuses on offering products, technologies, and services that facilitate the safe, efficient, and cost-effective extraction of oil and gas through artificial lift and digital automation applications. The Drilling Technologies provides polycrystalline diamond cutter inserts, bearings, valves, and mining tools. The Reservoir Chemical Technologies relates to chemistry-oriented solutions and technologies. The company was founded in 1882 and is headquartered in The Woodlands, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
O'Dell William Jr. See remarks Mar 28 '24 Sale 36.00 27,178 978,408 57,748 Mar 28 06:43 PM Bryant Deric D. See remarks Oct 02 '23 Sale 35.24 12,232 431,072 305,159 Oct 03 06:04 PM Bryant Deric D. See remarks Oct 03 '23 Sale 35.02 6,540 229,014 298,619 Oct 03 06:04 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite